Zoledronic acid in pediatric metabolic bone disorders
- 1 October 2017
- journal article
- review article
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 6 (4) , 256-268
Abstract
Zoledronic acid (ZA), a highly potent intravenous bisphosphonate (BP), has been increasingly used in children with primary and secondary osteoporosis due to its convenience of shorter infusion time and less frequent dosing compared to pamidronate. Many studies have also demonstrated beneficial effects of ZA in other conditions such as hypercalcemia of malignancy, fibrous dysplasia (FD), chemotherapy-related osteonecrosis (ON) and metastatic bone disease. This review summarizes pharmacologic properties, mechanism of action, dosing regimen, and therapeutic outcomes of ZA in a variety of metabolic bone disorders in children. Several potential novel uses of ZA are also discussed. Safety concerns and adverse effects are also highlighted.Keywords
This publication has 73 references indexed in Scilit:
- Zoledronic acid improves bone mineral density in pediatric spinal cord injuryJournal of Bone and Mineral Research, 2012
- Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agentsOncology Reports, 2010
- Response to zolendronic acid in children with type III osteogenesis imperfectaJournal of Bone and Mineral Metabolism, 2010
- Glucocorticoid-induced osteoporosis: treatment update and reviewTherapeutic Advances in Musculoskeletal Disease, 2009
- Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic reviewDevelopmental Medicine & Child Neurology, 2009
- Hypercalcemia in Acute Lymphoblastic LeukemiaJournal of Pediatric Hematology/Oncology, 2009
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Acute phase response and mineral status following low dose intravenous zoledronic acid in childrenBone, 2007
- Radiographic vertebral morphology: A diagnostic tool in pediatric osteoporosisThe Journal of Pediatrics, 2005
- Glucorticoids and Bone: Some General Remarks and Some Special Observations in Pediatric PatientsCalcified Tissue International, 2002